Literature DB >> 34547280

Beyond Metoclopramide for Gastroparesis.

Michael Camilleri1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34547280      PMCID： PMC8688280          DOI： 10.1016/j.cgh.2021.08.052

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN： 1542-3565            Impact factor:   11.382


× No keyword cloud information.
  8 in total

Review 1.  Clinical practice. Diabetic gastroparesis.

Authors:  Michael Camilleri
Journal:  N Engl J Med       Date:  2007-02-22       Impact factor: 91.245

2.  Nausea and vomiting in gastroparesis: similarities and differences in idiopathic and diabetic gastroparesis.

Authors:  H P Parkman; E K Hallinan; W L Hasler; G Farrugia; K L Koch; J Calles; W J Snape; T L Abell; I Sarosiek; R W McCallum; L Nguyen; P J Pasricha; J Clarke; L Miriel; L Lee; J Tonascia; F Hamilton
Journal:  Neurogastroenterol Motil       Date:  2016-06-27       Impact factor: 3.598

3.  A small particle size diet reduces upper gastrointestinal symptoms in patients with diabetic gastroparesis: a randomized controlled trial.

Authors:  Eva A Olausson; Stine Störsrud; Håkan Grundin; Mats Isaksson; Stig Attvall; Magnus Simrén
Journal:  Am J Gastroenterol       Date:  2014-01-14       Impact factor: 10.864

4.  Early satiety and postprandial fullness in gastroparesis correlate with gastroparesis severity, gastric emptying, and water load testing.

Authors:  H P Parkman; E K Hallinan; W L Hasler; G Farrugia; K L Koch; L Nguyen; W J Snape; T L Abell; R W McCallum; I Sarosiek; P J Pasricha; J Clarke; L Miriel; J Tonascia; F Hamilton
Journal:  Neurogastroenterol Motil       Date:  2016-10-25       Impact factor: 3.598

5.  Metoclopramide Nasal Spray Reduces Symptoms of Gastroparesis in Women, but not Men, With Diabetes: Results of a Phase 2B Randomized Study.

Authors:  Henry P Parkman; Marilyn R Carlson; Dave Gonyer
Journal:  Clin Gastroenterol Hepatol       Date:  2015-01-07       Impact factor: 11.382

Review 6.  Gastroparesis, metoclopramide, and tardive dyskinesia: Risk revisited.

Authors:  Ahmad Al-Saffar; Hans Lennernäs; Per M Hellström
Journal:  Neurogastroenterol Motil       Date:  2019-05-02       Impact factor: 3.598
  8 in total
  1 in total

1.  Management of Gastroparesis.

Authors:  Ting Zheng; Michael Camilleri
Journal:  Gastroenterol Hepatol (N Y)       Date:  2021-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.